Tech-Enabled NDIS Allied Health and PBS Provider – Gold Coast QLD

Southport QLD
Asking Price $8,500,000
Revenue
Profit
About
Business ID: XB167703

$5.4M revenue and $1.67M normalised EBITDA (31%) in FY2026, with referrals ahead of capacity and a lean, remote model built to scale nationally.

This NDIS-registered, multidisciplinary allied health and Positive Behaviour Support provider operates across South East Queensland, with telehealth services reaching participants interstate. Established in 2024, it was built as a technology-enabled platform rather than a clinic: services are delivered in participants’ homes, schools, workplaces and communities, while a remote central team handles intake, allocation, agreements and billing. The business now delivers approximately 400 clinical sessions a week through approximately 35 practitioners across Positive Behaviour Support, occupational therapy, psychology, speech pathology and physiotherapy. Revenue grew from $1.9 million in FY2025 to $5.4 million in FY2026, while normalised EBITDA rose from $229,556 to $1,666,010 and the margin widened from 12.0% to 31.0%. Its main capital investment is already made and operational: a customised CRM, a linked workflow platform, an AI-assisted report review tool and live capacity and quality dashboards. A virtual reality project for therapy and behaviour support is at the research and design stage and is available for an incoming owner to develop. Demand currently exceeds capacity, with approximately 200 prospective participants waiting and five additional behaviour support practitioners commencing in November 2026.

   -  Registered across six NDIS registration groups, with favourable audits rated at the highest level of practice in most sections.

   -  Revenue of $5,375,510 in FY2026, up 182% on FY2025.

   -  Normalised EBITDA of $1,666,010; margin up from 12.0% (FY2025) to 31.0% (FY2026).

   -  Gross margin up from 48.3% (FY2025) to 57.3% (FY2026).

   -  Net profit margin of 33.1%, against an industry average of 10% to 17%.

   -  Customised CRM, workflow platform, AI-assisted report review and live dashboards – already built and in daily use.

   -  Virtual reality therapy project at research and design stage, available for an incoming owner to develop.

   -  Runs under management: a General Manager, intake manager, clinical leads and four remote administration staff support approximately 35 practitioners.

   -  Approximately 200 prospective participants on the waiting list and 35 to 50 new referrals a week.

   -  Approximately 330 referring organisations, 173 of them new in the last 12 months.

   -  Highly diversified: no participant above 0.61% of FY2026 revenue.

   -  Organic search drives 61% of enquiries; paid advertising paused because demand exceeds capacity – clear marketing upside.

   -  No clinic leases or fit-outs; administration works remotely across three states.

   -  Sessions reconciled and claimed weekly; 91.0% of receivables current or under one month.

   -  Five additional behaviour support practitioners commencing November 2026.

The vendor will provide a transition period as required by the purchaser, covering referrer introductions, systems, governance and the management team; the length and terms are to be agreed. The General Manager is expected to continue in the business, and the employed team and contracted practitioners are expected to remain subject to their existing arrangements. The price includes goodwill, the customised systems and intellectual property, documented processes, plant and equipment, the referral network and normal working capital. Cash is excluded and work in progress is adjusted at settlement. The systems are fully implemented and in daily use. Vendor finance is not available.

The business suits an established allied health or disability services group seeking immediate scale and a ready-built operating platform; a strategic acquirer wanting a technology-enabled base for national expansion; or a financially capable investor comfortable with a managed business. It combines strong recent growth, a 31% normalised EBITDA margin and demand ahead of capacity with systems designed to add practitioners and regions without matching growth in overheads. To receive the Mini Information Memorandum, contact the agent and sign a Confidentiality Agreement.

Asking price: $8,500,000

This represents approximately 5.1x FY2026 normalised EBITDA of $1,666,010. The price includes goodwill, systems and intellectual property, plant and equipment, the referral network and normal working capital, on a cash-free, debt-free basis. Cash is excluded and work in progress is adjusted at settlement.

Property Code: 4895
        
Ref Num: xcllusive_51_2845
Contact this seller
What's your enquiry about?
Listed By: Last Updated 27 Oct 2026
Contact this seller
What's your enquiry about?
Listed By: Last Updated 27 Oct 2026